According to Focus Report Store, the global insulin pump market is growing at a CAGR of 9.10% during 2024-2030.
Looking for More Information? Click: https://www.focusreports.store/report/insulin-pump-market
Report Scope:
Market Size (2030): USD 7.27 Billion
Market Size (2024): USD 4.31 Billion
CAGR (2024-2030): 9.10%
Historic Year: 2021-2023
Base Year: 2024
Forecast Year: 2025-2030
Largest Region (2024): North America
Fastest-Growing Region: Asia Pacific
Segments By: Product Type, Insulin Pump, Indication Type, End-Users, And Geography
Geographic Analysis: North America, Europe, APAC, Latin America, And The Middle East & Africa
Market Overview
The insulin pumps market is experiencing significant growth, driven by the rising prevalence of diabetes, rapid advancements in medical technology, and a growing demand for precise and convenient diabetes management solutions. This upward trend is further supported by the increasing incidence of diabetes—particularly type 1—and the expanding adoption of advanced insulin delivery technologies.
A key factor contributing to this growth is the global surge in diabetes cases. Today, more than 589 million adults between the ages of 20 and 79 are living with diabetes, accounting for 1 in every 10 individuals. According to the International Diabetes Federation (IDF), this number is expected to reach 853 million by 2050. The majority of these individuals—approximately 3 in 4 reside in low- and middle-income countries. Diabetes continues to pose one of the most pressing public health challenges worldwide, contributing to around 6.7 million deaths in 2021 alone, which equates to one death every five seconds.
Transforming Diabetes Care: Rising Adoption of Automated Insulin Delivery (AID) Systems
The rising adoption of Automated Insulin Delivery (AID) systems marks a transformative shift in the global insulin pump market, driven by continuous technological innovation and proactive industry efforts. These advanced systems integrate continuous glucose monitors (CGMs) with insulin pumps to create a closed-loop mechanism that enables real-time blood glucose monitoring and automated insulin delivery. This integration not only simplifies diabetes management but also significantly improves patient outcomes. Clinical evidence highlights the benefits of AID systems, including a 10% average increase in time-in-range, reduced risk of diabetic ketoacidosis-related hospitalizations, and fewer instances of hypoglycemia. As healthcare providers and patients increasingly recognize the value of these systems, leading industry players are accelerating their adoption through product innovation and strategic initiatives.
Notable examples include Insulet’s launch of the Omnipod 5 and Medtronic’s release of the MiniMed 780G, both of which have driven substantial growth in their respective diabetes care portfolios. The growing prominence of AID systems signals a new era of personalized, tech-enabled diabetes care poised to reshape treatment standards globally.
Technological Advances in Insulin Pumps Driving Market Growth
Technological advancements are reshaping the insulin pump market, with innovations like Bluetooth-enabled devices and smartphone-controlled systems enhancing diabetes management. These features enable real-time communication between insulin pumps, continuous glucose monitors (CGMs), and smartphones, allowing users to monitor and adjust insulin delivery with ease. For instance, Insulet’s Omnipod DASH and Tandem’s t:slim X2 with Dexcom G6 CGM offer seamless integration and predictive tools that help prevent hypoglycemia. Additionally, systems like Medtronic’s MiniMed 780G represent a major step forward, using advanced algorithms to automatically adjust insulin every five minutes, bringing diabetes care closer to the functionality of a natural pancreas. These advancements mark a significant step forward in delivering personalized, responsive, and effective diabetes management solutions.
Recent Development
In 2025, the Tandem Diabetes Care received US FDA clearance & commercial launch for its next-generation automated insulin delivery (AID) algorithm, Control-IQ+ technology (Control-IQ+), for use by people with type 2 diabetes ages 18 and older.
In 2022, Medtronic announced the reimbursement for its MiniMed 770 G insulin pump system covered by the US Medicare and available with reimbursement in some countries. The primary reimbursement has been expanded in North & South American countries.
North America Leads, APAC Shows Fastest Growth
North America dominates and holds the largest global insulin pump market share of over 38%. North America stands as the dominant region in the global insulin pump market, driven by advanced healthcare infrastructure, high diabetes prevalence, and widespread adoption of medical technologies. The US and Canada have been at the forefront of insulin pump innovation, usage, and regulatory advancements. North America, particularly the US, stands as the most mature market for insulin pumps. The region benefits from a well-established healthcare system, high diabetes prevalence, robust insurance coverage, and the presence of leading insulin pump manufacturers such as Medtronic and Tandem Diabetes Care. In addition, the presence of market players and greater access to the insulin pump solution with higher economic stability give a boost to the market growth. Medtronic, Insulet, and Tandem Diabetes Care are the three major companies which has significant market penetration in the region.
The APAC region is expected to grow at the fastest CAGR of 10.84% during the forecast period. The APAC region presents a significant burden of diabetes. According to the IDF, countries like China and India have some of the highest numbers of people living with diabetes globally. Rising urbanization, sedentary lifestyles, and dietary changes have contributed to a surge in both Type 1 and Type 2 diabetes, particularly in urban and middle-income populations. The regulatory landscape in APAC is evolving, with a growing emphasis on patient safety and medical device efficacy. Countries such as Japan, South Korea, and Australia have well-established regulatory bodies that closely evaluate insulin pump products before approval.
Key Vendors
Insulet
Medtronic
Tandem Diabetes Care
Other Prominent Vendors
CeQur Simplicity
Debiotech SA
EOFLOW
F. Hoffmann-La Roche
IA Collaborative Holdings
Jiangsu Delfu medical device
LenoMed Medical
MannKind
Medtrum Technologies
Medzer
MicroPort Scientific
MicroTech Medical
Novo Nordisk
Shanghai Umitai Medical Technology
SOOIL Developments
Terumo
ViCentra B.V.
YPSOMED AG
Modular Medical
Beta Bionics
Market Segmentation & Forecasts
Product
Insulin Pump
Consumables
Tethered Pump
Patch Pump
Indication
Type 1 Diabetes
Type 2 Diabetes
End-Users
Hospitals
Home Healthcare Settings
Others
Geography
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Russia
Netherlands
APAC
China
Japan
India
South Korea
Australia
Latin America
Brazil
Mexico
Argentina
Columbia
Middle East & Africa
Turkey
Saudi Arabia
South Africa
In a nutshell, the Arizton Advisory & Intelligence market research report provides valuable market insights for industry stakeholders, investors, researchers, consultants, and business strategists aiming to gain a thorough understanding of the global insulin pump market. Request for Free Sample to get a glance of the report now: https://www.focusreports.store/report/insulin-pump-market
Other Related Reports that Might be of Your Business Requirement
Global Blood Glucose Monitoring Devices Market – Focused Insights 2024-2029
https://www.focusreports.store/report/blood-glucose-monitoring-devices-market-focused-insights
Blood Culture Tests Market – Global Outlook & Forecast 2024-2029
What Key Findings Will Our Research Analysis Reveal?
How big is the global insulin pump market?
How are technological advancements impacting the market?
What is the growth rate of the global insulin pump market?
What is driving the growth of the global insulin pump market?
Are insulin pumps used for both Type 1 and Type 2 diabetes?
Who are the key players in the global insulin pump market?
Why Arizton?
100% Customer Satisfaction
24×7 availability – we are always there when you need us
200+ Fortune 500 Companies trust Arizton’s report
80% of our reports are exclusive and first in the industry
100% more data and analysis
1500+ reports published till date
Post-Purchase Benefit
1hr of free analyst discussion
10% off on customization
About Us:
Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.
We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.
Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.
Media ContactCompany Name: Arizton Advisory & Intelligence Contact Person: JessicaEmail: Send EmailPhone: +1 3122332770Country: United StatesWebsite: https://www.focusreports.store/report/insulin-pump-market
